Differential ErbB receptor expression and intracellular signaling activity in lung adenocarcinomas and squamous cell carcinomas
Authors:
- María Dolores LudeñaMLMaría Dolores Ludeña
- Gonzalo VarelaGVGonzalo Varela
- José García PichelJosé García Pichel
- 1 July 2009
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 65 (1) , 25-33
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Src-Family Kinases Are Activated in Non-Small Cell Lung Cancer and Promote the Survival of Epidermal Growth Factor Receptor-Dependent Cell LinesThe American Journal of Pathology, 2007
- Her2-Targeted Therapies in Non–Small Cell Lung CancerClinical Cancer Research, 2006
- Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancerLung Cancer, 2006
- Epidermal growth factor receptor (EGFR) signaling in cancerGene, 2006
- Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancerNature Clinical Practice Oncology, 2005
- Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung CancerJNCI: Journal of the National Cancer Institute, 2005
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences, 2004
- Adenocarcinoma of the lung in young patientsCancer, 2000
- Stat3: a STAT Family Member Activated by Tyrosine Phosphorylation in Response to Epidermal Growth Factor and Interleukin-6Science, 1994